Baric Transcribed Interview (Redacted) — page 101

DC.Scheduling@LexitasLegal.com MS. SALAZAR: Or national security. That was also an exemption. DR. BARIC: I don't know what you mean by that. MS. SALAZAR: Yeah. I'm just saying it was. I wasn't -- DR. BARIC: So anyway, all the work with pseudotypes was not subject to gain, right. These are single-hit vectors that can't cause disease. As soon as we made full molecular clones, or chimeras, they were done in a WIV backbone, which meant that they're putting a zoonotic spike into a zoonotic strain, to eventually identify vaccine formulations that would be used in the cave, that's not subject to gain-of-function. MS. SALAZAR: It's not. DR. BARIC: That's not, according to my records. And in the grant in the very beginning it says that's not subject to gain-of-function. Now, if I remember correctly there is one sentence in there somewhere that says that we will consider potentially moving spike gene, or furin cleavage site into SARS coronavirus. That is definitely gain-of-function and would have to be reviewed before anything else was done. But that occurred boom, boom, boom, boom. You know, we're talking about eight steps down the line, where you gain a significant amount of data about the role of each spike, its ability to use different